uBiome Appoints Dr. Brandon Wuerth, MD, Founder of IBDwatch, to its Medical Advisory Board
SAN FRANCISCO, Nov. 26, 2018
SAN FRANCISCO, Nov. 26, 2018 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, announces the addition of Dr. Brandon Wuerth, MD, Founder of the website IBDwatch and Gastroenterology Fellow at the University of Louisville, to its Medical Advisory Board. Joining the board of leading scientists and doctors from around the world, Dr. Wuerth will bring to uBiome knowledge and research on IBD. The appointment will help uBiome continue its advancement in human microbiome research.
"Through his website and his practice, Dr. Wuerth has touched the lives of many sufferers of intestinal and gut disorders," Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. "His interest in bringing research about IBD to the public aligns with uBiome's mission and he will be a great asset to our board of medical advisors."
Dr. Wuerth completed his internal medicine residency at the Medical University of South Carolina and is currently a second-year Gastroenterology Fellow at the University of Louisville. A sufferer of Inflammatory Bowel Disease (IBD) himself, he founded the popular website IBDwatch to broadcast news and research pertaining to IBD to both physicians and patients. His prior research has been primarily focused on gastrointestinal hemorrhage and Clostridium difficile infection, the leading bacterial cause of healthcare-associated diarrhea, and has authored three publications.
About joining uBiome's Medical Advisory Board, Dr. Wuerth said, "I am honored to serve on uBiome's advisory board as they are a true pioneer in the field and give physicians a useful tool to improve patient care. I'm eager to work with them to advance research on the link between the microbiome and IBD."
In addition to Dr. Wuerth, the uBiome Scientific Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Liz Lipski (Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company's Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children's Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
Founded in 2012, uBiome is the leader in microbial genomics. The Company's mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.
uBiome's commercial products include SmartGut™, the world's first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn's Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women's health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.
uBiome's platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.
Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company's Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.